NewEdge Advisors’s Hims & Hers Health HIMS Stock Holding History

NewEdge Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$753K	Sell	21,721 -16,452	-43%	-$442K	﹤0.01%	1857
2026 Q1	$792K	Buy	38,173 +7,800	+26%	+$184K	﹤0.01%	1645
2025 Q4	$986K	Sell	30,373 -2,599	-8%	-$111K	﹤0.01%	1499
2025 Q3	$1.87M	Sell	32,972 -26,304	-44%	-$1.35M	0.01%	1052
2025 Q2	$2.95M	Buy	59,276 +58,886	+15,099%	+$2.66M	0.02%	764
2025 Q1	$11.5K	Sell	390 -19,631	-98%	-$729K	﹤0.01%	3047
2024 Q4	$484K	Buy	20,021 +9,105	+83%	+$226K	﹤0.01%	1580
2024 Q3	$201K	Buy	10,916 +10,408	+2,049%	+$186K	﹤0.01%	1998
2024 Q2	$10.3K	Buy	+508	New	+$8.45K	﹤0.01%	2853
2021 Q2	–	Sell	-10,100	Closed	-$134K	–	1164
2021 Q1	$134K	Buy	+10,100	New	+$169K	﹤0.01%	971

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NewEdge Advisors's HIMS Position: Q2 2026 in Review

NewEdge Advisors reduced its Hims & Hers Health (HIMS) stake by 43% in Q2 2026, selling an estimated $442K and leaving 21,721 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

NewEdge Advisors first reported a position in HIMS in Q1 2021 and has held it in 10 quarters since. The position peaked at $2.95M in Q2 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

NewEdge Advisors held 21,721 shares of Hims & Hers Health worth $753K as of Q2 2026.
NewEdge Advisors sold 16,452 Hims & Hers Health shares in Q2 2026, an estimated $442K.
Hims & Hers Health made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1857 holding.
NewEdge Advisors first reported a position in Hims & Hers Health in Q1 2021 and has held it in 10 quarters since.
NewEdge Advisors's Hims & Hers Health position peaked at $2.95M in Q2 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.